vs
爱德华生命科学（EW）与Sunrun Inc.（RUN）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Sunrun Inc.的1.4倍（$1.6B vs $1.2B），爱德华生命科学净利率更高（23.1% vs 8.9%，领先14.2%），Sunrun Inc.同比增速更快（123.5% vs 16.7%），过去两年Sunrun Inc.的营收复合增速更高（59.0% vs 9.7%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
Sunrun Inc.是美国知名的光伏系统及电池储能产品供应商，业务以服务住宅客户为主，2007年成立，总部位于加利福尼亚州旧金山，致力于为家庭用户提供高效的清洁能源解决方案。
EW vs RUN — 直观对比
营收规模更大
EW
是对方的1.4倍
$1.2B
营收增速更快
RUN
高出106.8%
16.7%
净利率更高
EW
高出14.2%
8.9%
两年增速更快
RUN
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $380.7M | $103.6M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | 8.4% |
| 净利率 | 23.1% | 8.9% |
| 营收同比 | 16.7% | 123.5% |
| 净利润同比 | 6.8% | 103.7% |
| 每股收益（稀释后） | $0.66 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRUN
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $724.6M | ||
| Q2 25 | $1.5B | $569.3M | ||
| Q1 25 | $1.4B | $504.3M | ||
| Q4 24 | $1.4B | $518.5M | ||
| Q3 24 | $1.4B | $537.2M | ||
| Q2 24 | $1.4B | $523.9M |
净利润EWRUN
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $103.6M | ||
| Q3 25 | $291.1M | $16.6M | ||
| Q2 25 | $333.2M | $279.8M | ||
| Q1 25 | $358.0M | $50.0M | ||
| Q4 24 | $385.6M | $-2.8B | ||
| Q3 24 | $3.1B | $-83.8M | ||
| Q2 24 | $366.3M | $139.1M |
毛利率EWRUN
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWRUN
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | 8.4% | ||
| Q3 25 | 19.8% | 0.5% | ||
| Q2 25 | 26.8% | -19.7% | ||
| Q1 25 | 27.9% | -22.8% | ||
| Q4 24 | 22.6% | -628.0% | ||
| Q3 24 | 25.9% | -23.8% | ||
| Q2 24 | 26.8% | -24.4% |
净利率EWRUN
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | 8.9% | ||
| Q3 25 | 18.7% | 2.3% | ||
| Q2 25 | 21.7% | 49.1% | ||
| Q1 25 | 25.3% | 9.9% | ||
| Q4 24 | 27.8% | -542.7% | ||
| Q3 24 | 226.7% | -15.6% | ||
| Q2 24 | 26.7% | 26.5% |
每股收益（稀释后）EWRUN
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $0.38 | ||
| Q3 25 | $0.50 | $0.06 | ||
| Q2 25 | $0.56 | $1.07 | ||
| Q1 25 | $0.61 | $0.20 | ||
| Q4 24 | $0.65 | $-12.59 | ||
| Q3 24 | $5.13 | $-0.37 | ||
| Q2 24 | $0.61 | $0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $14.7B |
| 股东权益账面价值 | — | $3.1B |
| 总资产 | — | $22.6B |
| 负债/权益比越低杠杆越低 | — | 4.69× |
8季度趋势，按日历期对齐
现金及短期投资EWRUN
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $2.0B | — |
总债务EWRUN
| Q1 26 | — | — | ||
| Q4 25 | — | $14.7B | ||
| Q3 25 | — | $14.6B | ||
| Q2 25 | — | $14.0B | ||
| Q1 25 | — | $13.6B | ||
| Q4 24 | — | $12.9B | ||
| Q3 24 | — | $12.5B | ||
| Q2 24 | — | $12.0B |
股东权益EWRUN
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $3.1B | ||
| Q3 25 | $10.2B | $3.0B | ||
| Q2 25 | $10.5B | $2.9B | ||
| Q1 25 | $10.1B | $2.6B | ||
| Q4 24 | $10.0B | $2.6B | ||
| Q3 24 | $9.5B | $5.3B | ||
| Q2 24 | $7.4B | $5.4B |
总资产EWRUN
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $22.6B | ||
| Q3 25 | $13.3B | $22.2B | ||
| Q2 25 | $13.5B | $21.2B | ||
| Q1 25 | $13.0B | $20.4B | ||
| Q4 24 | $13.1B | $19.9B | ||
| Q3 24 | $13.0B | $22.1B | ||
| Q2 24 | $10.1B | $21.4B |
负债/权益比EWRUN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.69× | ||
| Q3 25 | — | 4.90× | ||
| Q2 25 | — | 4.80× | ||
| Q1 25 | — | 5.19× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 2.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $96.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.94× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EWRUN
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $96.9M | ||
| Q3 25 | $573.7M | $-121.5M | ||
| Q2 25 | $290.2M | $-292.7M | ||
| Q1 25 | $280.4M | $-104.2M | ||
| Q4 24 | $-127.5M | $-258.4M | ||
| Q3 24 | $351.8M | $-156.2M | ||
| Q2 24 | $371.5M | $-208.5M |
自由现金流EWRUN
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | — | ||
| Q3 25 | $516.2M | — | ||
| Q2 25 | $240.9M | — | ||
| Q1 25 | $224.4M | — | ||
| Q4 24 | $-177.3M | — | ||
| Q3 24 | $299.9M | $-156.4M | ||
| Q2 24 | $286.1M | — |
自由现金流率EWRUN
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | — | ||
| Q3 25 | 33.2% | — | ||
| Q2 25 | 15.7% | — | ||
| Q1 25 | 15.9% | — | ||
| Q4 24 | -12.8% | — | ||
| Q3 24 | 22.1% | -29.1% | ||
| Q2 24 | 20.9% | — |
资本支出强度EWRUN
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 3.8% | 0.0% | ||
| Q2 24 | 6.2% | — |
现金转化率EWRUN
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | 0.94× | ||
| Q3 25 | 1.97× | -7.33× | ||
| Q2 25 | 0.87× | -1.05× | ||
| Q1 25 | 0.78× | -2.08× | ||
| Q4 24 | -0.33× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 1.01× | -1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RUN
| Products | $692.3M | 60% |
| Customer Agreements | $435.2M | 38% |
| Manufactured Product Other | $56.7M | 5% |
| Incentives | $31.3M | 3% |
